1.Validation of the OMRON automated oscillometric blood pressure monitoring device HEM 7156 using the association for the advancement of medical instrumentation/european society of hypertension/international organization for standardization (AAMI/ESH/ISO) universal standard (ISO 81060-2:2018).
Benjamin A. BALMORES JR. ; Raymond V. OLIVA ; Deborah Ignacia DAVID-ONA ; Dolores D. BONZON ; Alejandro Bimbo F. DIAZ ; Arnold Benjamin C. MINA ; Marlon T. CO ; Erick S. MENDOZA ; Alberto A. ATILANO ; Leilani B. MERCADO-ASIS ; Adriel E. GUERRERO ; Lourdes Ella G. SANTOS
Philippine Journal of Cardiology 2025;53(2):52-57
BACKGROUND
Blood pressure (BP) is a vital sign that is essential in the management of hypertension, thus, there is a need for accurate measurement of BP. This will allow for proper diagnosis and management of hypertension preventing cardiovascular morbidity and mortality among Filipino patients.
METHODOLOGYThis validation study utilized the US Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) protocol for BP monitors. A total of eighty-five (85) participants had their BP measured using both the HEM 7156 and a validated aneroid sphygmomanometer. The same-sequential BP measurement was recommended to be used and a total of nine readings were collected per individual. The mean average of BP and standard deviation were extracted from the measurements. The AAMI/ESH/ISO recommends the use of certain criteria for individual BP readings (criterion 1) and individual participants (criterion 2). Appropriate statistical analysis was used for other demographic data.
RESULTSThe participants had an average age of 34 years, more than half were females, and not diagnosed with hypertension. Individuals who were diagnosed with hypertension had no other comorbidities and were on single pill only. The average arm circumference was 26.9 cm. Blood Pressure (BP) readings were adequate based on the protocol. Validity results showed that for criterion 1, systolic blood pressure (SBP) difference was 3.4 ± 7.4 mmHg, while diastolic blood pressure (DBP) was 2.0 ± 8.0 mmHg. The results for criterion 2 showed for SBP was 3.3 ± 5.3 mmHg, while DBP was 1.9 ± 6.6 mmHg. The results satisfied a passing grade on the validation protocol set by the AAMI/ESH/ISO.
CONCLUSIONThis study showed that OMRON HEM 7156 is validated as a BP apparatus and may be recommended for Philippine use.
Human ; Hypertension
2.2023 Philippine Working Group Consensus Statement on renal denervation therapy for the management of hypertension
Raymond Oliva ; Deborah Ignacia D. Ona ; Lourdes Ella G. Santos ; Felix Eduardo Punzalan ; John David Tan ; Gilbert Villela ; Benjamin Balmores ; Krizia Camille Yap-Uy ; Roberta Maria Cawed-Mende ; Jose Nicholas Cruz
Philippine Journal of Cardiology 2024;52(1):12-18
BACKGROUND
Hypertension is the most common risk factor for cardiovascular disease in the Philippines. Despite the availability of antihypertensive medications that are effective, safe, and tolerated by Filipino patients, the numbers of uncontrolled hypertensives are still increasing. Several factors play in the poor control of blood pressure, particularly resistant hypertension and hyperactive sympathetic nervous system. Renal denervation therapy is a novel device that has been shown to lower blood pressure in patients with resistant and difficult-to-treat hypertension and is deemed safe in clinical trials. A Philippine Working Group composed of specialists in cardiology, hypertension, vascular surgery, and clinical epidemiology has come up with consensus statements in identifying patients who will benefit from the procedure. Locally, there is a need to have hypertension centers treating uncontrolled and resistant hypertension and offer renal denervation therapy to appropriate Filipino patients.
Blood Pressure
Result Analysis
Print
Save
E-mail